Early serum HBV RNA combined with HBsAg response can predict HBeAg seroconversation in patients on Entecavir therapy (ClinicalTrials.gov (NCT03909191))-Reference-Cited by-同舟云学术

Early serum HBV RNA combined with HBsAg response can predict HBeAg seroconversation in patients on Entecavir therapy (ClinicalTrials.gov (NCT03909191))

Published:2022-04 Issue:4 Volume:84 Page:e10-e12
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Liu Yayun,Liao Wei,Xu Aijing,Yin Wei^ORCID,Yu Jiao,Fan WenHan,Xue Jianya,Liang Xuesong^ORCID

Funder

Shanghai Municipal Natural Science Foundation

Wu Jieping Medical Foundation

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference10 articles.

1. On-treatment HBV RNA dynamic predicts entecavir-induced HBeAg seroconversion in children with chronic hepatitis B;Wu;J Infect,2021

2. N.A. Terrault, N.H. Bzowej, K.-M. Chang, J.P. Hwang, M.M. Jonas, Murad6 M.H. AASLD Guidelines for Treatment of Chronic Hepatitis B. 2015.

3. Serum HBV RNA Dynamic and Drug Withdrawal Predictor Value in Patients With Chronic HBV Infection on Long-term Nucleos(t)ide Analogue (NA) Therapy;Liu;J Clin Gastroenterol,2020

4. Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks;Wang;Int J Infect Dis,2020

5. Serum HBV RNA as a Predictor of Peginterferon Alfa-2a Response in Patients With HBeAg-Positive Chronic Hepatitis B;van Bommel;J Infect Dis,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biogenesis of serum HBV RNA and clinical phenomena of serum HBV RNA in chronic hepatitis B patients before and after receiving nucleos(t)ide analogues therapy;Journal of Viral Hepatitis;2024-02-08